{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:12:59Z","timestamp":1770063179611,"version":"3.49.0"},"reference-count":26,"publisher":"Global Health and Education Projects, Inc","content-domain":{"domain":["mchandaids.org"],"crossmark-restriction":true},"short-container-title":["Int J MCH AIDS"],"abstract":"<jats:sec>\n                    <jats:title>Background and Objective<\/jats:title>\n                    <jats:p>Postpartum hemorrhage (PPH) remains a major concern in crisis-affected settings. There is a lack of strategies for implementing heat-stable carbetocin (HSC) and tranexamic acid (TXA) in humanitarian settings. This study aims to investigate the impact of a capacity-strengthening package on the utilization of uterotonics for PPH prevention, PPH detection, and utilization of TXA for PPH treatment in basic obstetric care clinics in humanitarian settings in Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multi-stepped implementation research study was conducted, wherein six select facilities utilized an intervention package encompassing provider training, an online community of practice, and wall-displayed PPH algorithms. Facilities were conveniently assigned to the same study sequence: T1 (routine care), a transition period for training; T2 (package without HSC and TXA); T3 (package with HSC); and T4 (package with HSC and TXA). The primary outcomes assessed trends in prophylactic uterotonic use (including HSC), visual diagnosis of hemorrhage, and HSC and TXA use for hemorrhage treatment. Analysis followed an intention-to-treat approach, adjusting for cluster effect and baseline characteristics. Pan-African Clinical Trials Registry: PACTR202302476608339.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From April 10, 2022, to April 4, 2023, 2299 women were recruited (T1: 643, T2: 570, T3: 580, T4: 506). Over 99% of all women received prophylactic uterotonics across the four phases, with oxytocin alone primarily used in T1 (93%) and T2 (92%) and HSC alone in T3 (74%) and T4 (54%) (T4\u2013T1 95% CI: 47.8\u201361.0). Hemorrhage diagnosis ranged from 1% to 4%. For hemorrhage treatment, universal oxytocin use in T1 and T2 decreased in T3 and T4 after HSC introduction (T4\u2013T1: 33%\u2013100%; 95% CI: \u2013100.0 to \u201330.9), and TXA use increased in T4 (T4\u2013T1: 33%\u20130%; 95% CI: \u20132.4 to 69.1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and Global Health Implications<\/jats:title>\n                    <jats:p>An intervention package to reinforce providers\u2019 capacity to prevent and treat PPH can result in substantial HSC utilization and a moderate TXA adoption in cold-chain-challenged humanitarian settings. It could be scaled up with continuous capacity development and supportive supervision to mitigate confusion between existing and new medications, such as the decreased use of oxytocin for PPH treatment. Maintaining investments in cold-chain strengthening remains critical to ensure the quality of oxytocin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/ijma_9_2023","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T08:54:03Z","timestamp":1729328043000},"page":"S46-S54","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postpartum Hemorrhage in Humanitarian Settings: Heat-Stable Carbetocin and Tranexamic Acid Implementation Study in Uganda"],"prefix":"10.21106","volume":"13","author":[{"given":"Nguyen Toan","family":"Tran","sequence":"first","affiliation":[{"name":"Australian Center for Public and Population Health Research, Faculty of Health, University of Technology, Sydney, NSW, Australia"},{"name":"Faculty of Medicine, University of Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kidza","family":"Mugerwa","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, Uganda Country Office UN House, Kololo, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Muwanguzi","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, Uganda Country Office UN House, Kololo, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Mwesigwa","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, Uganda Country Office UN House, Kololo, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Wasswa","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, Uganda Country Office UN House, Kololo, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willibald","family":"Zeck","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, Technical Division, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Seuc","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, Uganda Country Office UN House, Kololo, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catrin","family":"Schulte-Hillen","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, Humanitarian Response Division, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8847","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"10.25259\/IJMA_9_2023\/ref-1","volume-title":"WHO recommendations for the prevention and treatment of postpartum haemorrhage","author":"World Health Organization","year":"2012"},{"issue":"1","key":"10.25259\/IJMA_9_2023\/ref-3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/GRF.0b013e3181cc406d","article-title":"Postpartum hemorrhage: Epidemiology, risk factors, and causes","volume":"53","author":"Oyelese","year":"2010","journal-title":"Clin Obstet Gynecol."},{"issue":"2","key":"10.25259\/IJMA_9_2023\/ref-4","doi-asserted-by":"publisher","first-page":"CD007412","DOI":"10.1002\/14651858.CD007412.pub5","article-title":"Active versus expectant management for women in the third stage of labour","volume":"2","author":"Begley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.25259\/IJMA_9_2023\/ref-5","volume-title":"WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage","author":"World Health Organization","year":"2018"},{"key":"10.25259\/IJMA_9_2023\/ref-6","volume-title":"WHO Model Lists of Essential Medicines, 21st List 2019","author":"World Health Organization","year":"; 2019"},{"issue":"1","key":"10.25259\/IJMA_9_2023\/ref-8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12913-023-09263-4","article-title":"Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India","volume":"23","author":"Cook","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"10.25259\/IJMA_9_2023\/ref-9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.bpobgyn.2008.08.004","article-title":"Epidemiology of postpartum haemorrhage: A systematic review","volume":"22","author":"Carroli","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.25259\/IJMA_9_2023\/ref-10","doi-asserted-by":"publisher","first-page":"e3054","DOI":"10.1136\/bmj.e3054","article-title":"Effect of tranexamic acid on surgical bleeding: Systematic review and cumulative meta-analysis","volume":"344","author":"Ker","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.25259\/IJMA_9_2023\/ref-11","doi-asserted-by":"publisher","first-page":"CD004896","DOI":"10.1002\/14651858.CD004896.pub4","article-title":"Antifibrinolytic drugs for acute traumatic injury","volume":"2015","author":"Ker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10084","key":"10.25259\/IJMA_9_2023\/ref-12","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Shakur","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.25259\/IJMA_9_2023\/ref-13","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/ijerph19073765","article-title":"Implementing heat-stable carbetocin for postpartum haemorrhage prevention in low-resource settings: A rapid scoping review","volume":"19","author":"Tran","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"10.25259\/IJMA_9_2023\/ref-14","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.3390\/ijerph19127385","article-title":"Tranexamic acid for postpartum hemorrhage treatment in low-resource settings: A rapid scoping review","volume":"19","author":"Tran","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.25259\/IJMA_9_2023\/ref-15","volume-title":"World Bank Group country classifications by income level for FY24 (July 1, 2023-June 30, 2024)","author":"Hamadeh","year":"2023"},{"key":"10.25259\/IJMA_9_2023\/ref-16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12978-016-0154-8","article-title":"Incidence and risk factors for postpartum hemorrhage in Uganda","volume":"13","author":"Ononge","year":"2016","journal-title":"Reprod Health"},{"issue":"1","key":"10.25259\/IJMA_9_2023\/ref-17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijgo.2015.06.047","article-title":"A mixed-methods study of barriers and facilitators to the implementation of postpartum hemorrhage guidelines in Uganda","volume":"132","author":"Braddick","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.25259\/IJMA_9_2023\/ref-19","doi-asserted-by":"publisher","first-page":"f6753","DOI":"10.1136\/bmj.f6753","article-title":"Implementation research: What it is and how to do it","volume":"347","author":"Peters","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.25259\/IJMA_9_2023\/ref-20","article-title":"Package \u2018pwr\u2019","volume":"1","author":"Champely","year":"2018","journal-title":"R package version"},{"issue":"3","key":"10.25259\/IJMA_9_2023\/ref-21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2105\/ajph.94.3.361","article-title":"Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement","volume":"94","author":"Des Jarlais","year":"2004","journal-title":"Am J Public Health"},{"key":"10.25259\/IJMA_9_2023\/ref-22","doi-asserted-by":"publisher","first-page":"a2390","DOI":"10.1136\/bmj.a2390","article-title":"Improving the reporting of pragmatic trials: an extension of the CONSORT statement","volume":"337","author":"Zwarenstein","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.25259\/IJMA_9_2023\/ref-23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-020-03485-8","article-title":"Uterotonics for prevention of postpartum haemorrhage: EN-BIRTH multi-country validation study","volume":"21","author":"Ruysen","year":"2021","journal-title":"BMC Pregnancy and Childbirth"},{"issue":"12","key":"10.25259\/IJMA_9_2023\/ref-24","doi-asserted-by":"publisher","first-page":"CD011689","DOI":"10.1002\/14651858.CD011689.pub3","article-title":"Uterotonic agents for preventing postpartum haemorrhage: A network meta\u2010analysis","volume":"12","author":"Gallos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.25259\/IJMA_9_2023\/ref-25","first-page":"79","article-title":"Oxytocin infusion after oxytocin bolus and carbetocin bolus to reduce blood loss during and after cesarean section\u2014a randomized clinical trial","volume":"83","author":"Fahmy","year":"2015","journal-title":"Med J Cairo Univ"},{"issue":"6","key":"10.25259\/IJMA_9_2023\/ref-26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.11622\/smedj.2016107","article-title":"Postpartum blood loss: Visual estimation versus objective quantification with a novel birthing drape","volume":"57","author":"Lertbunnaphong","year":"2016","journal-title":"Singapore Med J"},{"issue":"3","key":"10.25259\/IJMA_9_2023\/ref-27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/01.AOG.0000137873.07820.34","article-title":"Estimating blood loss: Can teaching significantly improve visual estimation?","volume":"104","author":"Dildy","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.25259\/IJMA_9_2023\/ref-28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2303966","article-title":"Randomized trial of early detection and treatment of postpartum hemorrhage","volume":"389","author":"Gallos","year":"2023","journal-title":"N Engl J Med"},{"key":"10.25259\/IJMA_9_2023\/ref-29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-11-1","article-title":"The world health organization multicountry survey on maternal and newborn health: study protocol","volume":"11","author":"Souza","year":"2011","journal-title":"BMC health services research"}],"container-title":["International Journal of Maternal and Child Health and AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/mchandaids.org\/postpartum-hemorrhage-in-humanitarian-settings-heat-stable-carbetocin-and-tranexamic-acid-implementation-study-in-uganda\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/mchandaids.org\/postpartum-hemorrhage-in-humanitarian-settings-heat-stable-carbetocin-and-tranexamic-acid-implementation-study-in-uganda\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:24:03Z","timestamp":1770024243000},"score":1,"resource":{"primary":{"URL":"https:\/\/mchandaids.org\/index.php\/ijma\/article\/view\/84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":26,"alternative-id":["10.25259\/IJMA_9_2023"],"URL":"https:\/\/doi.org\/10.25259\/ijma_9_2023","relation":{},"ISSN":["2161-864X","2161-8674"],"issn-type":[{"value":"2161-864X","type":"electronic"},{"value":"2161-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"article-number":"S46"}}